• No results found

[PDF] Top 20 Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

Has 10000 "Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy" found on our website. Below are the top 20 most common "Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy".

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

... reconstitution after chemother- apy is important from an infectious disease standpoint, understanding the kinetics and biology behind this phenomenon is also important in the context of anti- cancer immunotherapy ... See full document

16

Midostaurin: an emerging treatment for acute myeloid leukemia patients

Midostaurin: an emerging treatment for acute myeloid leukemia patients

... AML patients confers a robust anti-blast response sufficient to bridge a minority of patients to ...induction chemotherapy may prolong survival in FLT3-ITD mutant ...(WT)-FLT3 patients to ... See full document

11

Immunity to Diphtheria, Pertussis, Tetanus, and Poliomyelitis in Children with Acute Lymphocytic Leukemia After Cessation of Chemotherapy

Immunity to Diphtheria, Pertussis, Tetanus, and Poliomyelitis in Children with Acute Lymphocytic Leukemia After Cessation of Chemotherapy

... Time course of antibody titer to poliomyelitis type I in group B patients at cessation of therapy and 3, 6, and 12 months after cessation of therapy, as well as after revaccinat,ion, 12 [r] ... See full document

10

High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia

High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia

... stem cell proliferation and differentiation ...in patients undergoing ...among patients who received chemotherapy, as well as identify patients who require strategies in selecting the ... See full document

10

THE EVALUATION OF VITAMIN C SUPPLEMENTATION ON NUTRITIONAL STATUS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING CHEMOTHERAPY

THE EVALUATION OF VITAMIN C SUPPLEMENTATION ON NUTRITIONAL STATUS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING CHEMOTHERAPY

... AML patients under ...these patients. The rate of patients prone to malnutrition and severe malnutrition has decreased by ...63 patients with leukemia in 3 hospitals of Tehran, 19.4% of ... See full document

7

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation.

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation.

... AML patients who developed cGVHD compared to the patients who did not develop ...problem after bone marrow transplantation, and it is important to understand if there is any relationship between ... See full document

10

Acute Myeloid Leukemia

Acute Myeloid Leukemia

... with chemotherapy 111 ; however, this agent is not yet approved in ...risk patients: HiDAC has been shown to be preferable over lower dose cytarabine in this cytogenetic group as well 26,107 but its ... See full document

45

Acute Myeloid Leukemia

Acute Myeloid Leukemia

... for patients with higher-risk AML, based on cytogenetic and molecular test ...stem cell transplantation early in treatment if he or she had a stem cell ...consolidation chemotherapy, ... See full document

52

Acute Myeloid Leukemia

Acute Myeloid Leukemia

... of patients without using high-dose ...stem cell transplantation should be offered as a part of postremission strategy to patients with favorable cytogenetics remains ...stem cell transplant ... See full document

25

Acute Myeloid Leukemia

Acute Myeloid Leukemia

... directly after remission oc- curred. 30,38 This trial randomized patients to receive either 2 courses of 25 days of ATO (5 days per week for 5 weeks) immediately after experiencing complete re- ... See full document

38

Acute Myeloid Leukemia

Acute Myeloid Leukemia

... pediatric patients who have AML, age at diag- nosis is associated inversely with the probability of ...424 patients less than 21 years of age, an age greater than 10 years at diagnosis was significantly ... See full document

29

Acute Myeloid Leukemia

Acute Myeloid Leukemia

... inferior leukemia-free survival and imminent morphologic relapse, supporting the use of RQ-PCR ...53 patients during consolidation therapy and was the first to establish clinically relevant MRD cut-off ... See full document

89

Acute Myeloid Leukemia

Acute Myeloid Leukemia

... of leukemia is frequently suggested by routine laboratory evaluation, prompt recognition of AML is required to prevent early com- ...treatment. Chemotherapy with standard regimens for AML is intense and ... See full document

11

Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

... only patients with primary AML whose leukemic cell karyotype was known and who were assigned to the uniform prolonged mainte- nance chemotherapy were ... See full document

9

Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

... of acute myeloid leukemia (AML) is expected to increase in conjunction with our ageing ...many patients relapse after transplant, prompting us to examine various ways that we can ... See full document

25

<p>Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia</p>

<p>Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia</p>

... old patients with AML and t-AML and also in patients with advanced MDS, the CAG regimen has achieved a high response ...in patients with the CAG regimen. 1,12 Importantly, in patients >60 y ... See full document

22

Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia

Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia

... AML patients in CR1 who have intermediate- or high-risk disease and a suitable donor; this procedure is not indicated for patients in CR1 with good-risk ...for patients in CR2 and beyond who are in ... See full document

17

Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia

Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia

... phenotypes after > 30 days of ...the B-ALL+A2D group differentiated into less alizarin red stain positive osteoblast than that from the Ctr + A2D ...the B-ALL+A2D group (Fig. 2c). This result ... See full document

14

Decitabine in the treatment of acute myeloid leukemia in elderly patients

Decitabine in the treatment of acute myeloid leukemia in elderly patients

... elderly patients in clinical trials, median survival is still dismal at 7–12 months, with a 7% 2-year sur- vival in some ...Induction chemotherapy is also associated with significant upfront morbidity, with ... See full document

9

Aberrant Phenotype in Iranian Patients with Acute Myeloid Leukemia

Aberrant Phenotype in Iranian Patients with Acute Myeloid Leukemia

... Bone marrow analysis A bone marrow smear was prepared for microscopic examination. Bone marrow aspirate was checked for clot existence, if any was present, it was disintegrated with wooden sticks. In order to remove any ... See full document

5

Show all 10000 documents...